| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8477603 | Molecular and Cellular Endocrinology | 2012 | 8 Pages |
Abstract
⺠GLP-2 has been linked to carcinogenesis. ⺠The GLP-2 analogue teduglutide reduces inflammation in Crohn's disease patients. ⺠We found GLP-2 receptors in GIST tumor cells and in myenteric nerves in Crohn. ⺠GLP-2 receptors in GIST may be in vivo targets for radioactive GLP-2 analogs. ⺠The myenteric GLP-2 receptors may be teduglutide targets in Crohn's disease.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cell Biology
Authors
Meike Körner, Ruth Rehmann, Jean Claude Reubi,